What lies ahead of the APAC interventional neuroradiology sector?

The global market is expected to exceed $50b by 2032.

The Asia-Pacific interventional neuroradiology sector is expanding rapidly, with the global market projected to exceed $50b by 2032, according to DelveInsight.

The region is driven by improving healthcare infrastructure, rising expenditures, and the increasing incidence of cerebrovascular diseases.

“China and India are key markets benefiting from a surge in medical tourism,” the report said.

Moreover, government initiatives to improve stroke care and the presence of international device manufacturers are further driving growth.

Globally, the rising prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations is fuelling the demand for interventional neuroradiology.